Abstract
Atherosclerosis is still the chief cause of morbidity and mortality in developed nations. In Indonesia, even though infectious disease is still the chief health problem, degenerative disease, including atherosclerosis, has become an important health problem. The most recent development and management of coronary heart disease, both in reducing risk factors, establishing a diagnosis, and intervention is still unsatisfactory. Surgical intervention requires complete facilities at high costs. Even though in developed nations the modification of risk factors is already able to peduce the prevalence rate of atherosclerosis, such reduction is starting to slow down. [1] [2] [3] Such condition has stimulated researchers to identify environmental exposures including infection, that can influence the process of atherosclerosis. [4] [5] [6] Sero-epidemiological and pathological studies as well as laboratory animal studies and clinical data demonstrate that chronic infection by C.pneumoniae, Cytomegalovirus, and H.pylori may play a role in the pathogenesis of atherosclerosis. Even though there has been many studies associated with the process of atherosclerosis, the exact relationship between atherosclerosis and infection is still unclear.
Meta analysis demonstrated a relationship between an increase in C.pneumoniae antibody and the prevalence of coronary heart disease. 7 Saiko first reported a case control study in post-acute myocardiac infarction and chronic coronary heart disease that demonstrated an increase in pneumoniae antibody compared to control subjects. 8 Shor first reported C.pneumoniae in atherosclerosis lesion under the electron microscope. 9 Ramirez found that C.pneumoniae can be cultured from atherosclerotic plaques. 10 Cytomegalovirus is associated with primary atherosclerosis, post angioplasty re-stenosis and post-transplantation atherosclerosis. On the other hand, the association of H.pylori and atherogenesis is not as strong as the relationship between C.pneumoniae or CMV. 7, 11 In Indonesia, examinations for C.pneumoniae, CMV and H.pylori antibody associated with coronary heart disease has not been frequently reported.
METHODS
This study is a cross sectional study on patients that clinically demonstrate coronary heart disease and undergo cardiac catheterization. This study was conducted from March to August 1998. All study subjects that met the criteria were incorporated in the study (consecutive sampling) after stating informed consent. Patients that underwent cardiac catheterization undergo clinical and laboratory evaluation (blood glucose, cholesterol, triglyceride, and antibody for C.pneumoniae, Cytomegalovirus, and H.pylori). Evaluation for C.pneumoniae, cytomegalovirus, and H.pylori antibody were performed using the Elisa method. The statistical analysis used was the t-test and logistic regression.
RESULTS
There were 122 an study subjects that participated in this study. Most of the study subjects were male with an average age of 55 years. There were more nonsmokers than smokers. The initial data of the patients in this study can be found in Table 1 . The group with coronary stenosis compared to those without coronary stenosis did not demonstrate a significant difference in cholesterol and triglyceride level, as seen in Table 2 . There was no significant difference in the antibody levels in groups with stenosis and without, as seen in Table 3 . 
DISCUSSION
This study is a cross-sectional study. Evaluation of the levels of C.pneumoniae, CMV, and H.pylori antibodies was conducted prior to heart catheterization examination. C.pneumoniae, CMV, and H.pylori antibodies was evaluated by the evaluation of IgG antibodies evaluation, signifying past infection. In this study, we were not able to demonstrate a significant difference in the anti-C.pneumoniae, CMV, and H.pylori IgG levels in groups with and without stenosis. Even though this group was classified into those with coronary stenosis and those without, it does not mean that those in the group without stenosis did not suffer from atherosclerosis. Coronary stenosis is an advanced stage of the atherosclerotic process.
Proof that associated C.pneumoniae infection and atherosclerosis was conducted sero-epidemiologically, through direct detection of bacterial components in the atherosclerotic lesion and isolation of the bacteria from carotid and coronary atherome tissue. Many seroepidemiological studies have associated increased C.pneumoniae serology with myocardial infarction, coronary heart disease, and stroke. Prospective studies that have been performed do not provide strong evidence that support a relationship between C.pneumoniae, cytomegalovirus, and H.pylori infection with coronary heart disease. In C.pneumoniae infection, the riskratio towards coronary heart disease is 1.22 (95% CI 0.96-1.54), the risk ratio for cytomegalovirus is 0.91 (95%, CI 0.69-1.19), and the risk ratio for H.pylori is 1.13 (95%, 0.93-1.38). 12 Even though we must understand the diagnostic criteria, the limit of the titer used may be different. We also have to take into consideration the possibility of confounding factors such as smoking, and also the number of samples being studied.
14 In addition, when performing the evaluation, we also need to consider the fact that over 50% adults have antibodies against C.pneumoniae. The evaluation of antibody levels should be conducted serially, since there is a tendency for reinfection, thus causing fluctuation of the antibody serum. 12, 13 Melnich reported that patients that undergo coronary bypass surgery have an increased CMV antibody of 70%, compared to 43% in control subjects.
14 Pathological studies using PCR for CMV found 57% in atherosclerotic plaques and 36% in control subjects. Zhou reported that CMV infection is a strong independent risk factor for the development of post-atherectomy re-stenosis. 15 In patients positive for CMV, atherosclerosis of the graft occurs in 68.8% cases, while occurring in only 36.8% in patients with negative CMV. 16 Mendal reported that patients with positive H.pylori serology, there is a twofold risk of coronary heart disease. 17 Patel reported a correlation between H.pylori, C.pneumoniae, and coronary heart disease. 18 Rathbone et al, reported no correlation between H.pylori and coronary heart disease. 19 Paseri reported infection of a bacteria more virulent that Cag-A positive strain of H.pylori demonstrating a significant correlation with coronary heart disease. 20 From the pathological evaluation of 50 patients with abdominal aortal aneurysm, the DNA of H.pylori was not found in the atherosclerosis plaque. 7 The presence of microbes or their components in atherosclerotic lesions is estimated to be the initiating factor for the exacerbation of disease, but can not directly be concluded as the causative agent.
Influencing factors in the risk of coronary heart disease in this study was total cholesterol, HDL cholesterol, and triglyceride. This was in accordance with various studies that have taken place. It seems that infectious agents are not sufficient to cause atherosclerosis by themselves, but instead do so in conjunction with other risk factors for the development of atherosclerosis, such as smoking, hyperlipidemia, hypertension, etc.
Studies on human subjects, such as this one, are usually focused on advanced stages of atherosclerosis. Animal studies, on the other hand, are able to study earlier stages of the disease. Such condition needs to be understood, since the exposure to infection during childhood is common. In addition, available studies do not sufficiently consider past infection, whether it is active, persistent, recurrent, or latent. To be able to produce more reliable results, we need to conduct studies with serial antibody level evaluation of a larger number of samples, on homogenous population, with early onset of the disease. The Center for Disease Control and Prevention and Laboratory Center for Disease Control, which conducted a workshop in Canada, recommended to increase the reproducibility and comparability of C.pneumoniae studies. [21] [22] Studies conducted now a days are those that study the interaction between infection, traditional risk factors, and other determinants of host susceptibility, such as gender and nutrition.
CONCLUSION
In this study conducted on 122 people undergoing heart catheterization, we found a significant difference in cholesterol, triglyceride, and HDL levels between those with coronary stenosis and those without.
However, we did not find a significant difference in the levels of C.pneumoniae, CMV, and H.pylori antibodies. This study is unable to conclude the influence of these antibodies on atherosclerosis, since in the non-stenosis group, we cannot eliminate the possibility of atherosclerosis, since the average age of study subjects is 55 years. Studies on the interaction between infection and traditional risk factors as well as gender and nutrition is needed to find a clear answer of the influence of infection in atherosclerosis.
